Dr. Vipul Jairath
Claim this profileLondon Health Sciences Centre
Studies Crohn's Disease
Studies Ulcerative Colitis
14 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Vipul Jairath is currently running
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting0 awards Phase 21 criteria
Colonoscopy Screening
for Colorectal Cancer Risk in IBD
We will conduct a multicenter, parallel-group, non-inferiority RCT in persons with IBD undergoing colorectal neoplasia screening with high-definition white light colonoscopy, comparing a strategy of sampling visible lesions alone to a conventional strategy of sampling both visible lesions as well as normal-appearing mucosa using non-targeted biopsies. The primary outcome is the neoplasia detection rate. The required sample size to demonstrate non-inferiority is 1952 persons.
Recruiting1 award N/A1 criteria
More about Vipul Jairath
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Vipul Jairath has experience with
- Vedolizumab
- Mirikizumab
- TAK-279
- 5-ASA Withdrawal
- Treatment Algorithm A
- Treatment Algorithm B
Breakdown of trials Vipul Jairath has run
Crohn's Disease
Ulcerative Colitis
Colitis
Inflammatory Bowel Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vipul Jairath specialize in?
Vipul Jairath focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Vipul Jairath currently recruiting for clinical trials?
Yes, Vipul Jairath is currently recruiting for 7 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Vipul Jairath has studied deeply?
Yes, Vipul Jairath has studied treatments such as Vedolizumab, Mirikizumab, TAK-279.
What is the best way to schedule an appointment with Vipul Jairath?
Apply for one of the trials that Vipul Jairath is conducting.
What is the office address of Vipul Jairath?
The office of Vipul Jairath is located at: London Health Sciences Centre, London, Ontario N6A 5A5 Canada. This is the address for their practice at the London Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.